Robert S. Benjamin
About
Robert S. Benjamin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine.
According to data from OpenAlex, Robert S. Benjamin has authored 490 papers receiving a total of 25.6k indexed citations (citations by other indexed papers that have themselves been cited), including 267 papers in Pulmonary and Respiratory Medicine, 210 papers in Oncology and 106 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert S. Benjamin's work include Sarcoma Diagnosis and Treatment (220 papers), Vascular Tumors and Angiosarcomas (65 papers) and Cardiac tumors and thrombi (59 papers). Robert S. Benjamin is often cited by papers focused on Sarcoma Diagnosis and Treatment (220 papers), Vascular Tumors and Angiosarcomas (65 papers) and Cardiac tumors and thrombi (59 papers). Robert S. Benjamin collaborates with scholars based in United States, United Kingdom and France. Robert S. Benjamin's co-authors include Shreyaskumar Patel, Raphael E. Pollock, Peter W. T. Pisters, Sewa S. Legha, Nicholas R. Bachur, Haesun Choi, Gunar K. Zagars, Matthew T. Ballo, Carl Plager and Homer A. Macapinlac and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Oncology.
In The Last Decade
Robert S. Benjamin
476 papers receiving 24.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Robert S. Benjamin United States | 89 | 14.0k | 11.8k | 5.8k | 4.2k | 3.9k | 490 | 25.6k | ||
| Ian Judson United Kingdom | 79 | 16.5k 1.2× | 10.8k 0.9× | 3.3k 0.6× | 5.0k 1.2× | 6.0k 1.6× | 403 | 28.0k | ||
| Samuel Singer United States | 90 | 16.7k 1.2× | 8.1k 0.7× | 3.9k 0.7× | 4.9k 1.1× | 7.3k 1.9× | 331 | 28.9k | ||
| Paolo G. Casali Italy | 83 | 19.2k 1.4× | 8.3k 0.7× | 4.1k 0.7× | 5.8k 1.4× | 2.1k 0.6× | 431 | 25.2k | ||
| Peter W. T. Pisters United States | 93 | 17.6k 1.3× | 16.9k 1.4× | 2.9k 0.5× | 11.2k 2.6× | 1.5k 0.4× | 299 | 27.5k | ||
| M. van Glabbeke Belgium | 65 | 18.4k 1.3× | 15.5k 1.3× | 1.7k 0.3× | 9.7k 2.3× | 4.5k 1.1× | 198 | 36.0k | ||
| Jean‐Yves Blay France | 109 | 26.9k 1.9× | 19.4k 1.7× | 5.7k 1.0× | 7.3k 1.7× | 5.5k 1.4× | 1.2k | 45.8k | ||
| George D. Demetri United States | 93 | 23.7k 1.7× | 11.1k 0.9× | 3.2k 0.5× | 8.9k 2.1× | 6.6k 1.7× | 346 | 38.0k | ||
| Peter Hohenberger Germany | 57 | 9.0k 0.6× | 5.1k 0.4× | 2.0k 0.3× | 3.8k 0.9× | 1.2k 0.3× | 369 | 13.8k | ||
| Patrick Schöffski Belgium | 68 | 9.5k 0.7× | 9.6k 0.8× | 1.5k 0.3× | 3.2k 0.8× | 4.8k 1.2× | 510 | 19.4k | ||
| Antoîne Italiano France | 67 | 9.2k 0.7× | 9.0k 0.8× | 2.1k 0.4× | 2.6k 0.6× | 4.0k 1.0× | 618 | 17.5k |
Countries citing papers authored by Robert S. Benjamin
Since
Specialization
Citations
This map shows the geographic impact of Robert S. Benjamin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Benjamin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Benjamin more than expected).
Fields of papers citing papers by Robert S. Benjamin
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Robert S. Benjamin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Benjamin. The network helps show where Robert S. Benjamin may publish in the future.
Co-authorship network of co-authors of Robert S. Benjamin
This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Benjamin. A scholar is included among the top collaborators of Robert S. Benjamin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Benjamin. Robert S. Benjamin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Subbiah, Vivek, Pete Anderson, Kalevi Kairemo, et al.. (2019). Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial. Clinical Cancer Research. 25(13). 3802–3810.
2.
Subbiah, Vivek, Ravi Murthy, David S. Hong, et al.. (2018). Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers. Clinical Cancer Research. 24(16). 3845–3856.
3.
Subbiah, Vivek, Salah-Eddine Lamhamedi-Cherradi, Branko Cuglievan, et al.. (2018). Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival. Clinical Cancer Research. 24(19). 4865–4873.
4.
Schvartsman, Gustavo, Michael J. Wagner, Behrang Amini, et al.. (2017). Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients. Scientific Reports. 7(1). 9519–9519.
5.
Naing, Aung, Patricia LoRusso, Siqing Fu, et al.. (2012). Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing's Sarcoma Family Tumors. Clinical Cancer Research. 18(9). 2625–2631.
6.
Pappo, Alberto S., Shreyaskumar Patel, John Crowley, et al.. (2011). R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study. Journal of Clinical Oncology. 29(34). 4541–4547.
7.
Chugh, Rashmi, J. Kyle Wathen, Shreyaskumar Patel, et al.. (2010). Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial. Clinical Cancer Research. 16(19). 4884–4891.
8.
Maki, Robert G., J. Kyle Wathen, Shreyaskumar Patel, et al.. (2007). Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002. Journal of Clinical Oncology. 25(19). 2755–2763.
9.
Lev, Dina, Caimiao Wei, Matthew T. Ballo, et al.. (2007). Optimizing Treatment of Desmoid Tumors. Journal of Clinical Oncology. 25(13). 1785–1791.
10.
McAuliffe, John C., Alexander J. Lazar, Dan Yang, et al.. (2007). Association of Intratumoral Vascular Endothelial Growth Factor Expression and Clinical Outcome for Patients with Gastrointestinal Stromal Tumors Treated with Imatinib Mesylate. Clinical Cancer Research. 13(22). 6727–6734.
11.
Rosen, Lee S., Razelle Kurzrock, Marilyn Mulay, et al.. (2007). Safety, Pharmacokinetics, and Efficacy of AMG 706, an Oral Multikinase Inhibitor, in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 25(17). 2369–2376.
12.
Benjamin, Robert S., Sant P. Chawla, C. Humberto Carrasco, et al.. (1990). Primary chemotherapy for osteosarcoma with systemic adriamycin and intra-arterial cisplatin. 42(5). 314–317.
13.
Parkinson, David, Moshe Talpaz, Sewa S. Legha, et al.. (1989). Interlenkin-2 alone and in combination with other cytokines in melanoma: the investigational approach at the University of Texas M. D. Anderson Cancer Center. Cancer Treatment Reviews. 16. 39–48.
14.
Legha, Sewa S., Robert S. Benjamin, & Brendan J. MacKay. (1981). Reutilization of adriamycin in previously treated patients. Proceedings of the American Association for Cancer Research. 22.
15.
Benjamin, Robert S., et al.. (1979). An endomyocardial biopsy study of anthracycline-induced cardiomyopathy - detection, reversibility and potential amelioration. Proceedings of the American Association for Cancer Research. 20.
16.
Benjamin, Robert S., Michael J. Keating, Kenneth D. Swenerton, S S Legha, & K. B. McCredie. (1979). Clinical studies with rubidazone.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 63(5). 925–9.
17.
Legha, Sewa S., Robert S. Benjamin, H. Y. Yap, & E. J. Freireich. (1979). Augmentation of adriamycin's therapeutic index by prolonged continuous i.v. infusion for advanced breast cancer. Proceedings of the American Association for Cancer Research. 20.
18.
Bedikian, Agop Y., et al.. (1979). Chemotherapy for sarcoma of the stomach.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 63(3). 411–4.
19.
Hall, S. W., Robert S. Benjamin, & Manuel Valdivieso. (1978). Clinical pharmacokinetics of gallium nitrate (GA): a new metal anticancer agent. Proceedings of the American Association for Cancer Research. 19.
20.
Legha, Sewa S., Jordan U. Gutterman, Stephen W. Hall, et al.. (1978). Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(11 Pt 1). 3712–6.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ian Judson Breakdown of academic impact, for papers by Samuel Singer Breakdown of academic impact, for papers by Paolo G. Casali Breakdown of academic impact, for papers by Peter W. T. Pisters Breakdown of academic impact, for papers by M. van Glabbeke Breakdown of academic impact, for papers by Jean‐Yves Blay Breakdown of academic impact, for papers by George D. Demetri Breakdown of academic impact, for papers by Peter Hohenberger Breakdown of academic impact, for papers by Patrick Schöffski Breakdown of academic impact, for papers by Antoîne Italiano